This hypothesis is supported by the observation that peripheral blood mononuclear cells (PBMCs) taken from MS patients displayed defective HP1α recruitment to the TNFα promoter, while also displaying an accumulation of H3 with the double R8cit, K9me3 modification [135]. Here, TNF is linked to myeloid sarcoma.